Core Laboratories (CLB) Stock Statistics & Valuation Metrics

Core Laboratories has a market cap or net worth of $700.31M. The enterprise value is $729.40M.

Core Laboratories has 46,563,390 shares outstanding. The number of shares has decreased by -2.65% in one year.

Core Laboratories’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 7.93%.

The current PE Ratio of Core Laboratories is 21.8. Core Laboratories’s PEG ratio is -1.70.

In the last 12 months, Core Laboratories had revenue of 523.85M and earned 31.40M in profits. Earnings per share was 0.67.

In the last 12 months, operating cash flow was 50.49M and capital expenditures -15.63M, giving a free cash flow of 34.87M billion.

Core Laboratories pays an annual dividend of $0.01, resulting in a dividend yield of 0.27%

Core Laboratories upcoming earnings date is Feb 4, 2026, After Close (Confirmed).

Core Laboratories as a current ratio of 2.32, with Debt / Equity ratio of 14.97%

In the past 12 months, Core Laboratories has paid 14.03M in taxes.

Core Laboratories EV to EBITDA ratio is 13.28, with an EV/FCF ratio of 22.43.

Core Laboratories has $25.63M in cash and marketable securities with $167.10M in debt, giving a net cash position of -$141.47M billion.

Gross margin is 17.12%, with operating margin of 11.18%, and net profit margin of 5.99%.

The average price target for Core Laboratories is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell